Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
59.32
-1.76 (-2.88%)
Nov 17, 2026, 4:00 PM EST
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 27.59 billion as of November 17, 2026. It is the 4,047th most valuable company in the world and the 548th biggest in China. Its market cap has decreased by 8.30% in one year.
Market Cap
27.59B
Enterprise Value
23.29B
Revenue
4.98B
Global Rank
Country Rank
#548 China
PE Ratio
8.00
ChartMarket Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 27.59B, an increase of 67.84%. That is a compound annual growth rate of 11.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 27.59B | 3.87% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 33.22B |
| Dong-E-E-Jiao | 33.17B |
| Beijing Tongrentang | 33.07B |
| Shenzhen Salubris Pharmaceuticals | 31.29B |
| Changchun High-Tech Industry (Group) | 30.10B |
| Hubei Jumpcan Pharmaceutical | 28.76B |
| Shijiazhuang Yiling Pharmaceutical | 25.65B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 25.22B |